Literature DB >> 21420502

DcR3 induces cell proliferation through MAPK signaling in chondrocytes of osteoarthritis.

S Hayashi1, T Nishiyama, Y Miura, T Fujishiro, N Kanzaki, S Hashimoto, T Matsumoto, M Kurosaka, R Kuroda.   

Abstract

INTRODUCTION: Decoy receptor 3 (DcR3), a soluble receptor belonging to the tumor necrosis factor (TNF) receptor superfamily, competitively binds and inhibits the TNF family including Fas-ligand (Fas-L), lymphotoxin-like inducible protein that competes with glycoprotein D for binding herpesvirus entry mediator on T-cells (LIGHT) and TNF-like ligand 1A (TL1A). In this study, we investigated the functions of DcR3 on osteoarthritis (OA) chondrocytes.
METHODS: Expressions of DcR3 in chondrocytes were measured by realtime Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR). Expression of DcR3 in sera and joint fluids was measured by enzyme-linked immunosorbent assay (ELISA). Chondrocytes were incubated with DcR3-Fc chimera protein (DcR3-Fc) before induction of apoptosis by Fas-L and apoptosis was detected with terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labelling labeling (TUNEL) staining and Western blotting of caspase 8 and poly (ADP-ribose) polymerase (PARP). Chondrocytes were incubated with DcR3-Fc and the proliferation was analyzed by 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate (WST) assay. Phosphorylation of Extracellular Signal-Regulated Kinase (ERK), P38 mitogen-activated protein kinase (MAPK) and Jun N-terminal Kinase (JNK) in chondrocytes was measured by Western blotting after incubation with DcR3-Fc, Mitogen-activated protein kinase kinase (MEK1/2) inhibitor, or P38 MAPK inhibitor. Chondrocytes were treated with DcR3-Fc after pre-incubation with blocking antibody of Fas-L, LIGHT and TL1A, and proliferation or phosphorylation of ERK was analyzed.
RESULTS: DcR3 was expressed in OA and normal chondrocytes. DcR3-Fc protects chondrocytes from Fas-induced apoptosis. DcR3-Fc increased chondrocytes proliferation and induced the phosphorylation of ERK specifically. DcR3-induced chondrocytes proliferation was inhibited by pre-incubation of PD098059 or blocking Fas-L antibody. DcR3 increased chondrocytes proliferation in OA chondrocytes, but did not in normal.
CONCLUSION: DcR3 regulates the proliferation of OA chondrocytes via ERK signaling and Fas-induced apoptosis.
Copyright © 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21420502     DOI: 10.1016/j.joca.2011.03.005

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  12 in total

1.  Primary human chondrocytes respond to compression with phosphoproteomic signatures that include microtubule activation.

Authors:  Donald L Zignego; Jonathan K Hilmer; Brian Bothner; William J Schell; Ronald K June
Journal:  J Biomech       Date:  2019-10-01       Impact factor: 2.712

2.  The involvement and possible mechanism of NR4A1 in chondrocyte apoptosis during osteoarthritis.

Authors:  Xinge Shi; Hui Ye; Xuedong Yao; Yanzheng Gao
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

3.  TNFSF15 Modulates Neovascularization and Inflammation.

Authors:  Zhisong Zhang; Lu-Yuan Li
Journal:  Cancer Microenviron       Date:  2012-07-26

4.  Activation of the extracellular-signal-regulated kinase (ERK)/c-Jun N-terminal kinase (JNK) signal pathway and osteogenic factors in subchondral bone of patients with knee osteoarthritis.

Authors:  Yaofeng Xu; Yuguo Gu; Wanbo Ji; Qirong Dong
Journal:  Ann Transl Med       Date:  2021-04

5.  Significance of decoy receptor 3 (Dcr3) and external-signal regulated kinase 1/2 (Erk1/2) in gastric cancer.

Authors:  Donghai Yang; Xin Fan; Ping Yin; Qiang Wen; Feng Yan; Sibo Yuan; Bin Liu; Guohong Zhuang; Zhongchen Liu
Journal:  BMC Immunol       Date:  2012-06-06       Impact factor: 3.615

6.  Acid-sensing ion channel 3 decreases phosphorylation of extracellular signal-regulated kinases and induces synoviocyte cell death by increasing intracellular calcium.

Authors:  Weiyi Gong; Sandra J Kolker; Yuriy Usachev; Roxanne Y Walder; David L Boyle; Gary S Firestein; Kathleen A Sluka
Journal:  Arthritis Res Ther       Date:  2014-06-12       Impact factor: 5.156

Review 7.  Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions.

Authors:  Shie-Liang Hsieh; Wan-Wan Lin
Journal:  J Biomed Sci       Date:  2017-06-19       Impact factor: 8.410

8.  siRNA targeting decoy receptor 3 enhances the sensitivity of gastric carcinoma cells to 5-fluorouracil.

Authors:  Xiao-Tao Xu; Ze-Zhang Tao; Qi-Bin Song; Yi Yao; Peng Ruan
Journal:  Exp Ther Med       Date:  2012-06-08       Impact factor: 2.447

9.  'Decoy' and 'non-decoy' functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cells.

Authors:  Mitsunori Toda; Teruya Kawamoto; Takeshi Ueha; Kenta Kishimoto; Hitomi Hara; Naomasa Fukase; Yasuo Onishi; Risa Harada; Masaya Minoda; Masahiro Kurosaka; Toshihiro Akisue
Journal:  Int J Oncol       Date:  2013-06-28       Impact factor: 5.650

10.  p21 deficiency is susceptible to osteoarthritis through STAT3 phosphorylation.

Authors:  Shinya Hayashi; Takaaki Fujishiro; Shingo Hashimoto; Noriyuki Kanzaki; Nobuaki Chinzei; Shinsuke Kihara; Koji Takayama; Tomoyuki Matsumoto; Kotaro Nishida; Masahiro Kurosaka; Ryosuke Kuroda
Journal:  Arthritis Res Ther       Date:  2015-11-07       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.